Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
EU health regulator urges immediate vaccinations amid early surge in flu cases - 2A volcanic eruption may have catalyzed the plague's arrival in Europe, study suggests
- 3Flu concerns grow in US as UK sees more cases among kids
- 4Manual for Notorious Fragrances: Immortal Aromas
- 5Lahav 433 head Asst.-Ch. Meni Benjamin named as police officer investigated for breach of trust
- Activist vessel collides with krill trawler in Antarctic confrontation
- Artemis 2 astronauts — now halfway to the moon — report 'burning smell' from toilet, but everything's fine
- Judge sets $60K bond for Florida congresswoman accused of stealing $5M in COVID-19 funds
- 'Stranger Things' character guide: The nerds, the newcomers and the rest of the Season 5 cast
- Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025
- 'A completely new manufacturing frontier': Space Forge fires up 1st commercial semiconductor factory in space
- Artemis II astronauts arrive at Florida launch site for first moon trip in 53 years
- IndiGo lands IATA chief Willie Walsh as new CEO
- You finally got a doctor's appointment. Here's how to get the most out of it
